These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 34803655)
1. Nicotinamide Adenine Dinucleotide Phosphate Oxidases Are Everywhere in Brain Disease, but Not in Huntington's Disease? Villegas L; Nørremølle A; Freude K; Vilhardt F Front Aging Neurosci; 2021; 13():736734. PubMed ID: 34803655 [TBL] [Abstract][Full Text] [Related]
2. Elevated NADPH oxidase activity contributes to oxidative stress and cell death in Huntington's disease. Valencia A; Sapp E; Kimm JS; McClory H; Reeves PB; Alexander J; Ansong KA; Masso N; Frosch MP; Kegel KB; Li X; DiFiglia M Hum Mol Genet; 2013 Mar; 22(6):1112-31. PubMed ID: 23223017 [TBL] [Abstract][Full Text] [Related]
3. The Role of NADPH Oxidases and Oxidative Stress in Neurodegenerative Disorders. Tarafdar A; Pula G Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30513656 [TBL] [Abstract][Full Text] [Related]
4. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis. Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J Elife; 2021 Apr; 10():. PubMed ID: 33871358 [TBL] [Abstract][Full Text] [Related]
5. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys. Cho IK; Yang B; Forest C; Qian L; Chan AWS PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183 [TBL] [Abstract][Full Text] [Related]
6. Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington's disease. Nithianantharajah J; Hannan AJ Neuroscience; 2013 Oct; 251():66-74. PubMed ID: 22633949 [TBL] [Abstract][Full Text] [Related]
7. NADPH Oxidases in Neurodegenerative Disorders: Mechanisms and Therapeutic Opportunities. Fiadeiro MB; Diogo JC; Silva AA; Kim YS; Cristóvão AC Antioxid Redox Signal; 2024 Sep; 41(7-9):522-541. PubMed ID: 38760935 [No Abstract] [Full Text] [Related]
8. Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks. Mehler MF; Petronglo JR; Arteaga-Bracho EE; Gulinello ME; Winchester ML; Pichamoorthy N; Young SK; DeJesus CD; Ishtiaq H; Gokhan S; Molero AE J Neurosci; 2019 Mar; 39(10):1892-1909. PubMed ID: 30626701 [TBL] [Abstract][Full Text] [Related]
9. New insights on NOX enzymes in the central nervous system. Nayernia Z; Jaquet V; Krause KH Antioxid Redox Signal; 2014 Jun; 20(17):2815-37. PubMed ID: 24206089 [TBL] [Abstract][Full Text] [Related]
10. Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases. Wu P; Zuo X; Deng H; Liu X; Liu L; Ji A Brain Res Bull; 2013 Aug; 97():69-80. PubMed ID: 23756188 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review. Alqahtani T; Deore SL; Kide AA; Shende BA; Sharma R; Dadarao Chakole R; Nemade LS; Kishor Kale N; Borah S; Shrikant Deokar S; Behera A; Dhawal Bhandari D; Gaikwad N; Kalam Azad A; Ghosh A Mitochondrion; 2023 Jul; 71():83-92. PubMed ID: 37269968 [TBL] [Abstract][Full Text] [Related]